Use of Curcumin in Multiple Myeloma patients intolerant of steroid therapy

Abstract Curcumin, when used in a combination regimen in multiple myeloma patients, has comparable progression‐free survival without the adverse effects of steroid‐based combination therapies that is curcumin may be a viable alternative to corticosteroids in combination with an immunomodulatory drug...

Full description

Bibliographic Details
Main Authors: Rajeev Ramakrishna, Terrence H. Diamond, William Alexander, Arumugam Manoharan, Terry Golombick
Format: Article
Language:English
Published: Wiley 2020-04-01
Series:Clinical Case Reports
Subjects:
Online Access:https://doi.org/10.1002/ccr3.2735
Description
Summary:Abstract Curcumin, when used in a combination regimen in multiple myeloma patients, has comparable progression‐free survival without the adverse effects of steroid‐based combination therapies that is curcumin may be a viable alternative to corticosteroids in combination with an immunomodulatory drug or proteasome inhibitor.
ISSN:2050-0904